サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：セルライト治療市場規模、シェア＆動向分析レポート：施術タイプ別（非侵襲、低侵襲、局所）、セルライトタイプ別（ソフトセルライト、ハードセルライト）、エンドユーザー別、地域別、およびセグメント予測、2022年～2030年
市場調査レポート
商品コード
1122188

セルライト治療市場規模、シェア＆動向分析レポート：施術タイプ別（非侵襲、低侵襲、局所）、セルライトタイプ別（ソフトセルライト、ハードセルライト）、エンドユーザー別、地域別、およびセグメント予測、2022年～2030年

Cellulite Treatment Market Size, Share & Trends Analysis Report By Procedure Type (Non-invasive, Minimally Invasive, Topical), By Cellulite Type (Soft Cellulite, Hard Cellulite), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 101 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
セルライト治療市場規模、シェア＆動向分析レポート：施術タイプ別（非侵襲、低侵襲、局所）、セルライトタイプ別（ソフトセルライト、ハードセルライト）、エンドユーザー別、地域別、およびセグメント予測、2022年～2030年
出版日: 2022年08月19日
発行: Grand View Research
ページ情報: 英文 101 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

セルライト治療市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界のセルライト治療市場規模は2030年までに34億米ドルに達すると予想され、2022年から2030年まで11.3%のCAGRで拡大します。市場の成長は、座りがちなライフスタイルや不適切な食事による肥満の有病率の増加、これらの技術の有効性と安全性の向上に起因していると考えられます。また、政府の支援策も業界の成長に寄与すると期待されています。例えば、米国食品医薬品局（FDA）は2016年、低侵襲性セルライト治療法であるCellfinaを認可しました。Science Directが発表した記事によると、セルライトは思春期以降の女性の約80％が罹患し、最も耐え難い美的合併症の1つであると認識されています。このような疾患の高い有病率は、関連する社会的圧力とともに、業界の需要を促進すると予想されます。

COVID-19の大流行により、市場全体で売上、収益、業務に大きな損失が生じ、各国を財政危機に追い込みました。保健当局は、すべての美容クリニックに対して、緊急の場合を除き、患者の診察と治療を直ちに停止するよう命じ、その結果、オフィスが閉鎖され、業界全体で前例のない収益減少に見舞われました。2020年末になると、美容整形に対する需要が高まり、美容クリニックは有利な成長を遂げるようになりました。多くの美容外科医は、パンデミック時だけでなく、パンデミック後の状況においても、デジタルアプリケーションを介したオンライン診察を開始しました。

さらに、業界プレーヤーによって行われた新製品開発のイニシアチブは、業界の成長を後押しすることが期待されています。例えば、Endo International Plcは、Soliton, Inc.がセルライト治療のための非侵襲的治療のための臨床試験を開始した一方で、2020年末までにそのセルライト治療を起動すると予想されています。同市場は、予測期間中に大規模なM&Aや戦略的提携を示すと予想されています。これは、競争企業間の敵対関係を制限するために、既存のプレーヤーが市場統合に重点を置いていることに起因しています。例えば、インベスターズビジネスデイリー社の記事によると、アラガンは、エンドのセルライト治療の国際マーケティングのためのエンド-インターナショナルとのコラボレーションを模索すると推定されています。このコラボレーションは、Allerganのボディコントゥアリングとエステティックポートフォリオを補完することが期待されています。

セルライト治療市場レポートハイライト

非侵襲的な処置のタイプが2021年に最大の収益シェアを占めまており、これらの処置の高い可用性に起因しています。

ソフトセルライトタイプのセグメントは、予測期間中に有利な成長を示すと予想されます。簡単な除去プロセスとともに、このセルライトタイプの高い有病率は、市場の需要に燃料を供給すると予想されます。

クリニックとビューティーセンターのエンドユーズセグメントは、2021年に市場をリードし、予測期間中に急速に成長すると推定されます。

2021年に北米が主要地域となっています。これは、高度な医療インフラの存在、熟練した人材の存在、および同地域における美容および美容処置への比較的高い支出に起因しています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報と第三者の視点
    • 1次調査
  • 情報分析
    • データ分析モデル
  • 市場形成とデータ可視化
  • データの検証と公開

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 セルライト治療市場の変数、動向、範囲

  • 市場系列の見通し
    • 関連/補助的な市場の見通し
  • 浸透と成長の見通しのマッピング
  • 製品パイプライン分析
  • ユーザー視点分析
    • 消費者行動分析
    • 市場インフルエンサー分析
  • 規制の枠組み
    • 償還の枠組み
    • 規格とコンプライアンス
  • 市場力学
    • 市場促進要因分析
      • 肥満の蔓延
    • 市場制約分析
      • 高コスト
    • 業界の課題
  • セルライト治療：市場分析ツール
    • 業界分析- ポーターズ
      • サプライヤーの力
      • 買い手の交渉力
      • 代替の脅威
      • 新規参入者からの脅威
      • 競争企業間の敵対関係
    • PESTEL分析
      • 政治情勢
      • 環境情勢
      • 社会情勢
      • テクノロジー情勢
      • 法的情勢
    • 主要取引と戦略的提携分析
      • 合弁事業
      • 合併と買収
      • ライセンシングとパートナーシップ
      • 技術協力
      • 戦略的売却
      • 市場参入戦略

第4章 セルライト治療市場：セグメント分析、手順タイプ別、2018年から2030年（100万米ドル）

  • 定義と範囲
  • 手術タイプの市場シェア分析、2021年および2030年
  • セグメントダッシュボード
  • 世界のセルライト治療市場、手順の種類別、2018年から2030年
  • 2018年から2030年までの以下の市場規模と予測、トレンド分析
    • 非侵襲的
    • 低侵襲
    • 話題の

第5章 セルライト治療市場：セグメント分析、セルライトタイプ別、2018年～2030年（100万米ドル）

  • 定義と範囲
  • セルライトタイプの市場シェア分析、2021年と2030年
  • セグメントダッシュボード
  • 世界のセルライト治療市場、セルライトタイプ別、2018年から2030年
  • 2018年から2030年までの以下の市場規模と予測、トレンド分析
    • ソフトセルライト
    • ハードセルライト
    • 浮腫性セルライト

第6章 セルライト治療市場：セグメント分析、最終用途別、2018年から2030年（100万米ドル）

  • 定義と範囲
  • 最終用途の市場シェア分析、2021年と2030年
  • セグメントダッシュボード
  • 世界のセルライト治療市場、最終用途別、2018年から2030年
  • 2018年から2030年までの以下の市場規模と予測、トレンド分析
    • 病院
    • クリニックと美容センター

第7章 セルライト治療市場：地域別市場分析、2018年から2030年（100万米ドル）

  • 定義と範囲
  • 地域市場シェア分析、2021年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット（市場規模、 CAGR、トップバーティカル、キープレーヤー、トップ動向）
  • 2021年の地域市場シェアと主要企業
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 要因別SWOT分析（政治と法律、経済と技術）
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 市場規模、予測、トレンド分析、2022年から2030年：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • タイ
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 セルライト治療市場-競合分析

  • 主要な市場参加者別最近の動向と影響分析
  • 企業/競合の分類（主要なイノベーター、マーケットリーダー、新興企業）
  • ベンダー情勢
    • 主要なディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2021年
    • 企業の市況分析（収益、地理的プレゼンス、製品ポートフォリオ、主要なサービス可能産業、主要な提携）
  • サプライヤーランキング
  • Key companies profiled
    • Merz Pharma.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Hologic, Inc.（Cynosure）
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Syneron Medical
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Zimmer Aesthetics.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Tanceuticals, LLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Cymedics.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Nubway
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 Global Cellulite Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 3 Global Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 4 Global Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 5 North America Cellulite Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 North America Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 7 North America Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 8 North America Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 10 U.S. Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 14 Canada Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Cellulite Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 18 Europe Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 21 U.K. Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 22 U.K. Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 23 U.K. Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 24 U.K. Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 Germany Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 26 Germany Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 29 France Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 30 France Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 31 France Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 32 France Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 34 Italy Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 36 Italy Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 37 Spain Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 38 Spain Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 39 Spain Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 40 Spain Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Cellulite Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Japan Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 46 Japan Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 47 Japan Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 48 Japan Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 49 China Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 50 China Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 51 China Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 52 China Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 53 India Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 54 India Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 55 India Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 56 India Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 57 Thailand Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 58 Thailand Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 59 Thailand Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 60 Thailand Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 62 South Korea Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 64 South Korea Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65 Australia Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 66 Australia Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 67 Australia Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 68 Australia Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cellulite Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 70 Latin America Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 74 Brazil Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Mexico Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 78 Mexico Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 80 Mexico Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 81 Argentina Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 82 Argentina Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 83 Argentina Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 84 Argentina Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Cellulite Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 89 South Africa Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 90 South Africa Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 91 South Africa Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 92 South Africa Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)
  • Table 97 UAE Cellulite Treatment Market, 2018 - 2030 (USD Million)
  • Table 98 UAE Cellulite Treatment Market, By Procedure Type, 2018 - 2030 (USD Million)
  • Table 99 UAE Cellulite Treatment Market, By Cellulite Type, 2018 - 2030 (USD Million)
  • Table 100 UAE Cellulite Treatment Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cellulite treatment market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Market challenge relevance analysis (Current & future impact)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market penetration vs growth prospect mapping
  • Fig. 16 Cellulite treatment market: procedure type movement analysis
  • Fig. 17 Cellulite treatment market: cellulite type movement analysis
  • Fig. 18 Cellulite treatment market: end-use movement analysis
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 Regional outlook, 2021 & 2030
  • Fig. 21 North America Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 24 Europe Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 25 U.K. Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 27 Italy Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 28 Spain Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 France Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 30 Asia Pacific Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 Japan Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 32 China Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 India Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Thailand Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 South Korea Cellulite Treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Australia Cellulite Treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Latin America Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Brazil Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 Argentina Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 MEA Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 South Africa Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 Saudi Arabia Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 UAE Cellulite treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Strategy framework
目次
Product Code: GVR-2-68038-985-2

Cellulite Treatment Market Growth & Trends:

The global cellulite treatment market size is anticipated to reach USD 3.4 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.3% from 2022 to 2030. The market growth can be attributed to the increasing prevalence of obesity due to sedentary lifestyles and improper diet and improved efficacy and safety of these techniques. In addition, supportive government initiatives are expected to contribute to industry growth. For instance, the U.S. Food and Drug Administration (FDA) cleared Cellfina, a minimally invasive cellulite treatment, in 2016. According to an article published by Science Direct, cellulite affects nearly 80% of post-pubertal women and is perceived to be one of the most intolerable aesthetic complications. Such a high prevalence of the disease along with the associated social pressure is anticipated to fuel the industry demand.

The COVID-19 pandemic resulted in major losses across markets in terms of sales, revenues, and operations, pushing countries into financial crises. Health authorities ordered all aesthetic clinics to immediately stop seeing and treating patients, except in emergencies, resulting in office closures and unprecedented revenue decline across the sector. By the end of 2020, aesthetic clinics started witnessing lucrative growth as the demand for cosmetic procedures increased. Many cosmetic surgeons started online consultations during the pandemic as well as post-pandemic landscape via digital applications.

Furthermore, new product development initiatives undertaken by the industry players are anticipated to boost industry growth. For instance, Endo International Plc is anticipated to launch its cellulite treatment by the end of 2020 while Soliton, Inc. has initiated clinical trials for its non-invasive treatment for cellulite treatment. The market is anticipated to witness significant mergers & acquisitions and strategic collaborations during the forecast period. This can be attributed to the emphasis on market consolidation by established players to limit competitive rivalry. For instance, according to an article by Investor's Business Daily, Inc., Allergan is estimated to seek collaboration with Endo International for international marketing of Endo's cellulite treatment. This collaboration is anticipated to complement the body contouring and aesthetic portfolio of Allergan.

Cellulite Treatment Market Report Highlights:

  • Non-invasive procedure type held the largest revenue share in 2021. This can be attributed to the high availability of these procedures
  • The soft cellulite type segment is anticipated to witness lucrative growth over the forecast period. The high prevalence of this cellulite type along with the easy removal process is anticipated to fuel the market demand
  • The clinics and beauty centers end-use segment led the market in 2021 and is estimated to grow rapidly over the forecast period
  • North America emerged as the leading region in 2021. This can be attributed to the presence of advanced medical infrastructure, presence of skilled personnel, and comparatively higher expenditure on cosmetic and aesthetic procedures in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cellulite Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis
  • 3.4. User perspective analysis
    • 3.4.1. Consumer Behavior Analysis
    • 3.4.2. Market Influencer Analysis
  • 3.5. Regulatory Framework
    • 3.5.1. Reimbursement framework
    • 3.5.2. Standards & Compliances
  • 3.6. Market Dynamics
    • 3.6.1. Market Driver Analysis
      • 3.6.1.1. Growing prevalence of obesity
    • 3.6.2. Market Restraint Analysis
      • 3.6.2.1. High Cost
    • 3.6.3. Industry Challenges
  • 3.7. Cellulite Treatment: Market Analysis Tools
    • 3.7.1. Industry Analysis - Porter's
      • 3.7.1.1. Supplier Power
      • 3.7.1.2. Buyer Power
      • 3.7.1.3. Substitution Threat
      • 3.7.1.4. Threat from new entrant
      • 3.7.1.5. Competitive rivalry
    • 3.7.2. PESTEL Analysis
      • 3.7.2.1. Political Landscape
      • 3.7.2.2. Environmental Landscape
      • 3.7.2.3. Social Landscape
      • 3.7.2.4. Technology Landscape
      • 3.7.2.5. Legal Landscape
    • 3.7.3. Major Deals & Strategic Alliances Analysis
      • 3.7.3.1. Joint Ventures
      • 3.7.3.2. Mergers & Acquisitions
      • 3.7.3.3. Licensing & Partnership
      • 3.7.3.4. Technology Collaborations
      • 3.7.3.5. Strategic Divestments
      • 3.7.3.6. Market Entry Strategies

Chapter 4. Cellulite Treatment Market: Segment Analysis, By Procedure Type, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Procedure type market share analysis, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Cellulite Treatment Market, By Procedure Type, 2018 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Non-invasive
    • 4.5.2. Minimally invasive
    • 4.5.3. Topical

Chapter 5. Cellulite Treatment Market: Segment Analysis, By Cellulite Type, 2018 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Cellulite type market share analysis, 2021 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Cellulite Treatment Market, By Cellulite Type, 2018 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Soft cellulite
    • 5.5.2. Hard cellulite
    • 5.5.3. Edematous Cellulite

Chapter 6. Cellulite Treatment Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. End-use market share analysis, 2021 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Cellulite Treatment Market, By End-use, 2018 to 2030
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
    • 6.5.2. Clinics & Beauty Centers

Chapter 7. Cellulite Treatment Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. Regional market share analysis, 2021 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.5. Regional Market Share and Leading Players, 2021
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.6.1. North America
    • 7.6.2. Europe
    • 7.6.3. Asia Pacific
    • 7.6.4. Latin America
    • 7.6.5. Middle East & Africa
  • 7.7. Market Size, & Forecasts, and Trend Analysis, 2022 to 2030:
  • 7.8. North America
      • 7.8.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
      • 7.8.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.8.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.8.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.8.2. U.S.
      • 7.8.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.8.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.8.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.8.3. Canada
      • 7.8.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.8.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.8.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
  • 7.9. Europe
      • 7.9.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
      • 7.9.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.9.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.9.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.9.2. Germany
      • 7.9.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.9.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.9.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.9.3. U.K.
      • 7.9.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.9.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.9.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.9.4. France
      • 7.9.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.9.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.9.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.9.5. Italy
      • 7.9.5.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.9.5.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.9.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.9.6. Spain
      • 7.9.6.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.9.6.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.9.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
  • 7.10. Asia Pacific
      • 7.10.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
      • 7.10.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.10.2. China
      • 7.10.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.10.3. Japan
      • 7.10.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.10.4. India
      • 7.10.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.10.5. Thailand
      • 7.10.5.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.5.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.10.6. South Korea
      • 7.10.6.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.6.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.10.7. Australia
      • 7.10.7.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.10.7.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.10.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
  • 7.11. Latin America
      • 7.11.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
      • 7.11.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.11.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.11.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.11.2. Brazil
      • 7.11.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.11.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.11.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.11.3. Mexico
      • 7.11.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.11.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.11.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.11.4. Argentina
      • 7.11.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.11.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.11.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
  • 7.12. Middle East and Africa
      • 7.12.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
      • 7.12.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.12.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.12.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.12.2. South Africa
      • 7.12.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.12.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.12.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.12.3. Saudi Arabia
      • 7.12.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.12.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.12.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
    • 7.12.4. UAE
      • 7.12.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
      • 7.12.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
      • 7.12.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)

Chapter 8. Cellulite Treatment Market - Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2021
    • 8.3.4. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
  • 8.4. Supplier Ranking
  • 8.5. Key companies profiled
    • 8.5.1. Merz Pharma.
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Hologic, Inc. (Cynosure)
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Syneron Medical
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Zimmer Aesthetics.
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Tanceuticals, LLC
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Cymedics.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Nubway
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives